If care and thought are taken in designing an OTC program that is educational and emphasizes the adverse effects and potential drug−drug interactions, with the admonition that concerns should be ...
Timothy Klusas, the Company's President and Chief Executive Officer, stated, “The share repurchase authorization represents our financial strength and commitment to enhance shareholder value, and the ...